Metraipolis › archive › dc_1696d7adfac0
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors — Europe PMC PMID:42022812
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42022812
- DOI
- 10.3390/radiation5040039
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T18:56:51.220Z
- SHA-256 of the archived text
994df08c86192c0c0de1c5fa48c263e6dc3165da10fd22ea8eb02b32749dbad7- Stable URL of this page
https://metraipolis.com/documento/dc_1696d7adfac0
How to cite
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors — Europe PMC PMID:42022812 — Europe PMC (en), https://europepmc.org/article/MED/42022812 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1696d7adfac0 (Metraipolis archive dc_1696d7adfac0, sha256 994df08c86192c0c0de1c5fa48c263e6dc3165da10fd22ea8eb02b32749dbad7)
BibTeX
@misc{dc1696d7adfac0,
title = {Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors — Europe PMC PMID:42022812},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42022812},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1696d7adfac0; sha256 994df08c86192c0c0de1c5fa48c263e6dc3165da10fd22ea8eb02b32749dbad7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42022812. Agents can read the archived copy with the MCP tool read_document.